Jph. Wilding et al., ACUTE EFFECTS OF CENTRAL NEUROPEPTIDE-Y INJECTION ON GLUCOSE-METABOLISM IN FASTED RATS, Clinical science, 89(5), 1995, pp. 543-548
1. Neuropeptide Y is a potent appetite stimulant and has been found to
modulate glucose metabolism when given chronically. The acute effects
of neuropeptide on peripheral glucose handling have not been studied
in detail. We have studied the acute effects of central nervous system
injection of neuropeptide on glucose metabolism in vivo in the rat. 2
. Rats implanted with chronic cannulae in the third cerebral ventricle
were injected with either neuropeptide Y or saline and peripheral ins
ulin sensitivity was assessed during a hyperinsulinaemic euglycaemic c
lamp. The effect of centrally injected neuropeptide Y on post-absorpti
ve glucose metabolism was studied using a constant infusion of [6-H-3]
glucose. 3. Infusion of neuropeptide Y resulted in a 18% increase in g
lucose requirement during the clamp, suggesting increased peripheral t
issue responsiveness to insulin, Neuropeptide Y injection in 10 h fast
ed rats increased plasma glucose (area under curve 9.9+/-0.2 versus 9.
1+/-0.1 mmol h(-1) l(-1), P<0.01), insulin (103+/-23 versus 33+/-8 pmo
l/l, P<0.01, at 30 min) and glucagon (5.5+/-0.5 versus 3.1+/-0.3 pmol/
l, P<0.05, at 30 min). The increase in plasma glucose was due to an in
itial increase in the rate of appearance, which peaked between 20 and
30 min after neuropeptide Y infusion; over the entire 90 min 16% more
glucose entered the systemic circulation in the neuropeptide Y-treated
rats than in control rats, and the total quantity of glucose removed
was also greater. 4. Neuropeptide Y in the central nervous system infl
uences glucose metabolism by altering secretion of islet hormones, hep
atic glucose production and the peripheral response to insulin.